Loading…

Role of Constitutively Activated and Insulin-Like Growth Factor-Stimulated ERK1/2 Signaling in Human Hepatoma Cell Proliferation and Apoptosis: Evidence for Heterogeneity of Tumor Cell Lines

: Enhanced insulin‐like growth factor II (IGF‐II) and type I IGF receptor (IGF‐IR) gene expression in liver tumors and the development of liver tumors in transgenic mice overexpressing IGF‐II in the liver suggest that the IGFs and underlying signaling cascades may play auto/paracrine roles in the co...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the New York Academy of Sciences 2004-12, Vol.1030 (1), p.219-229
Main Authors: ALEXIA, CATHERINE, LASFER, MALIKA, GROYER, ANDRÉ
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4199-64076a63445284d65d902fa2d3aa15620d87cb40f26d07b5cedb4e47111c09693
cites cdi_FETCH-LOGICAL-c4199-64076a63445284d65d902fa2d3aa15620d87cb40f26d07b5cedb4e47111c09693
container_end_page 229
container_issue 1
container_start_page 219
container_title Annals of the New York Academy of Sciences
container_volume 1030
creator ALEXIA, CATHERINE
LASFER, MALIKA
GROYER, ANDRÉ
description : Enhanced insulin‐like growth factor II (IGF‐II) and type I IGF receptor (IGF‐IR) gene expression in liver tumors and the development of liver tumors in transgenic mice overexpressing IGF‐II in the liver suggest that the IGFs and underlying signaling cascades may play auto/paracrine roles in the control of hepatocarcinoma (HCC) cell proliferation and in their protection against apoptosis. We have focused on the role of mitogen‐activated protein kinase (ERK1/2) signaling on human HepG2 and Huh‐7 hepatoma cell proliferation and on the protection of these cells against drug‐induced apoptosis. Physiological concentrations of IGF‐I stimulated DNA replication in HepG2 cells (1.5‐fold) but not in Huh‐7 cells, and this effect was abolished by PD98059 (MEK‐1 inhibitor). Doxorubicin or cisplatin treatment induced apoptosis (caspase‐dependent poly[ADP‐ribose]polymerase cleavage) in both cell lines, but dose‐dependent reversion of drug‐induced apoptosis (57–84%) by IGF‐I was only observed in HepG2 cells. The very low level of IGF‐IR at the plasma membrane of Huh‐7 cells may account for their unresponsiveness to IGF‐I. We have shown that drug treatment enhanced (17‐fold) or did not modify constitutive ERK1/2 activity in cultured HepG2 or Huh‐7 cells, respectively. In both cell lines, inhibition of constitutive and drug‐induced ERK1/2 activity by PD98059 yielded a complete inhibition of drug‐induced apoptosis. Altogether, our data demonstrate the heterogeneous response of human hepatoma cells to an IGF stimulus and suggest (1) that auto/paracrine effects of IGF‐I/‐II might contribute to the proliferation of HCC cells and to their protection against apoptosis in vivo and (2) that drug‐induced activation of ERK1/2 plays a role in drug‐induced apoptosis in human hepatoma cells.
doi_str_mv 10.1196/annals.1329.028
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67218223</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67218223</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4199-64076a63445284d65d902fa2d3aa15620d87cb40f26d07b5cedb4e47111c09693</originalsourceid><addsrcrecordid>eNqFkc9v0zAcxSMEYmVw5oZ84pbWdhw74Vaq_pgoA61DEyfLTb4pZond2c5G_zn-NtymgiMX27I-7-npvSR5S_CYkJJPlDGq9WOS0XKMafEsGRHBypTzjD5PRhgLkRYlzS6SV97_xJjQgomXyQXJeV4WmIyS3ze2BWQbNLPGBx36oB-hPaBpFR8qQI2UqdGV8X2rTbrW94CWzj6FH2ihqmBdugm669sTOb_5RCYUbfQuhtJmh7RBq75T8YS9CrZTaAZti7462-oGnArampP_dG_3wXrtP6D5o67BVIAa66IugLM7MKDD4Zjytu_i98llrQ3418mLJhYAb873ZfJtMb-drdL1l-XVbLpOK0bK2AfDgiueMZbHBmqe1yWmjaJ1plTsguK6ENWW4YbyGottXkG9ZcAEIaTCJS-zy-T94Lt39qEHH2SnfRVjKAO295ILSgpKswhOBrBy1nsHjdw73Sl3kATL42RymEweJ5Nxsqh4d7butx3U__jzRhFgA_CkWzj8z09ef59uKDlGTgeZ9gF-_ZUpdx_TZiKXd9dLyVd3jK4-LuTn7A9xG7Uy</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67218223</pqid></control><display><type>article</type><title>Role of Constitutively Activated and Insulin-Like Growth Factor-Stimulated ERK1/2 Signaling in Human Hepatoma Cell Proliferation and Apoptosis: Evidence for Heterogeneity of Tumor Cell Lines</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>ALEXIA, CATHERINE ; LASFER, MALIKA ; GROYER, ANDRÉ</creator><creatorcontrib>ALEXIA, CATHERINE ; LASFER, MALIKA ; GROYER, ANDRÉ</creatorcontrib><description>: Enhanced insulin‐like growth factor II (IGF‐II) and type I IGF receptor (IGF‐IR) gene expression in liver tumors and the development of liver tumors in transgenic mice overexpressing IGF‐II in the liver suggest that the IGFs and underlying signaling cascades may play auto/paracrine roles in the control of hepatocarcinoma (HCC) cell proliferation and in their protection against apoptosis. We have focused on the role of mitogen‐activated protein kinase (ERK1/2) signaling on human HepG2 and Huh‐7 hepatoma cell proliferation and on the protection of these cells against drug‐induced apoptosis. Physiological concentrations of IGF‐I stimulated DNA replication in HepG2 cells (1.5‐fold) but not in Huh‐7 cells, and this effect was abolished by PD98059 (MEK‐1 inhibitor). Doxorubicin or cisplatin treatment induced apoptosis (caspase‐dependent poly[ADP‐ribose]polymerase cleavage) in both cell lines, but dose‐dependent reversion of drug‐induced apoptosis (57–84%) by IGF‐I was only observed in HepG2 cells. The very low level of IGF‐IR at the plasma membrane of Huh‐7 cells may account for their unresponsiveness to IGF‐I. We have shown that drug treatment enhanced (17‐fold) or did not modify constitutive ERK1/2 activity in cultured HepG2 or Huh‐7 cells, respectively. In both cell lines, inhibition of constitutive and drug‐induced ERK1/2 activity by PD98059 yielded a complete inhibition of drug‐induced apoptosis. Altogether, our data demonstrate the heterogeneous response of human hepatoma cells to an IGF stimulus and suggest (1) that auto/paracrine effects of IGF‐I/‐II might contribute to the proliferation of HCC cells and to their protection against apoptosis in vivo and (2) that drug‐induced activation of ERK1/2 plays a role in drug‐induced apoptosis in human hepatoma cells.</description><identifier>ISSN: 0077-8923</identifier><identifier>EISSN: 1749-6632</identifier><identifier>DOI: 10.1196/annals.1329.028</identifier><identifier>PMID: 15659801</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>apoptosis ; Apoptosis - drug effects ; Carcinoma, Hepatocellular - enzymology ; Carcinoma, Hepatocellular - pathology ; Cell Division ; Cell Line, Tumor ; DNA Replication - drug effects ; human hepatoma cell lines ; Humans ; Insulin-Like Growth Factor I - pharmacology ; Insulin-Like Growth Factor II - pharmacology ; insulin-like growth factors ; Liver Neoplasms - enzymology ; Liver Neoplasms - pathology ; MAP kinase (ERK) signaling ; Mitogen-Activated Protein Kinases - metabolism ; proliferation ; Signal Transduction - drug effects</subject><ispartof>Annals of the New York Academy of Sciences, 2004-12, Vol.1030 (1), p.219-229</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4199-64076a63445284d65d902fa2d3aa15620d87cb40f26d07b5cedb4e47111c09693</citedby><cites>FETCH-LOGICAL-c4199-64076a63445284d65d902fa2d3aa15620d87cb40f26d07b5cedb4e47111c09693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15659801$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ALEXIA, CATHERINE</creatorcontrib><creatorcontrib>LASFER, MALIKA</creatorcontrib><creatorcontrib>GROYER, ANDRÉ</creatorcontrib><title>Role of Constitutively Activated and Insulin-Like Growth Factor-Stimulated ERK1/2 Signaling in Human Hepatoma Cell Proliferation and Apoptosis: Evidence for Heterogeneity of Tumor Cell Lines</title><title>Annals of the New York Academy of Sciences</title><addtitle>Ann N Y Acad Sci</addtitle><description>: Enhanced insulin‐like growth factor II (IGF‐II) and type I IGF receptor (IGF‐IR) gene expression in liver tumors and the development of liver tumors in transgenic mice overexpressing IGF‐II in the liver suggest that the IGFs and underlying signaling cascades may play auto/paracrine roles in the control of hepatocarcinoma (HCC) cell proliferation and in their protection against apoptosis. We have focused on the role of mitogen‐activated protein kinase (ERK1/2) signaling on human HepG2 and Huh‐7 hepatoma cell proliferation and on the protection of these cells against drug‐induced apoptosis. Physiological concentrations of IGF‐I stimulated DNA replication in HepG2 cells (1.5‐fold) but not in Huh‐7 cells, and this effect was abolished by PD98059 (MEK‐1 inhibitor). Doxorubicin or cisplatin treatment induced apoptosis (caspase‐dependent poly[ADP‐ribose]polymerase cleavage) in both cell lines, but dose‐dependent reversion of drug‐induced apoptosis (57–84%) by IGF‐I was only observed in HepG2 cells. The very low level of IGF‐IR at the plasma membrane of Huh‐7 cells may account for their unresponsiveness to IGF‐I. We have shown that drug treatment enhanced (17‐fold) or did not modify constitutive ERK1/2 activity in cultured HepG2 or Huh‐7 cells, respectively. In both cell lines, inhibition of constitutive and drug‐induced ERK1/2 activity by PD98059 yielded a complete inhibition of drug‐induced apoptosis. Altogether, our data demonstrate the heterogeneous response of human hepatoma cells to an IGF stimulus and suggest (1) that auto/paracrine effects of IGF‐I/‐II might contribute to the proliferation of HCC cells and to their protection against apoptosis in vivo and (2) that drug‐induced activation of ERK1/2 plays a role in drug‐induced apoptosis in human hepatoma cells.</description><subject>apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Carcinoma, Hepatocellular - enzymology</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Cell Division</subject><subject>Cell Line, Tumor</subject><subject>DNA Replication - drug effects</subject><subject>human hepatoma cell lines</subject><subject>Humans</subject><subject>Insulin-Like Growth Factor I - pharmacology</subject><subject>Insulin-Like Growth Factor II - pharmacology</subject><subject>insulin-like growth factors</subject><subject>Liver Neoplasms - enzymology</subject><subject>Liver Neoplasms - pathology</subject><subject>MAP kinase (ERK) signaling</subject><subject>Mitogen-Activated Protein Kinases - metabolism</subject><subject>proliferation</subject><subject>Signal Transduction - drug effects</subject><issn>0077-8923</issn><issn>1749-6632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNqFkc9v0zAcxSMEYmVw5oZ84pbWdhw74Vaq_pgoA61DEyfLTb4pZond2c5G_zn-NtymgiMX27I-7-npvSR5S_CYkJJPlDGq9WOS0XKMafEsGRHBypTzjD5PRhgLkRYlzS6SV97_xJjQgomXyQXJeV4WmIyS3ze2BWQbNLPGBx36oB-hPaBpFR8qQI2UqdGV8X2rTbrW94CWzj6FH2ihqmBdugm669sTOb_5RCYUbfQuhtJmh7RBq75T8YS9CrZTaAZti7462-oGnArampP_dG_3wXrtP6D5o67BVIAa66IugLM7MKDD4Zjytu_i98llrQ3418mLJhYAb873ZfJtMb-drdL1l-XVbLpOK0bK2AfDgiueMZbHBmqe1yWmjaJ1plTsguK6ENWW4YbyGottXkG9ZcAEIaTCJS-zy-T94Lt39qEHH2SnfRVjKAO295ILSgpKswhOBrBy1nsHjdw73Sl3kATL42RymEweJ5Nxsqh4d7butx3U__jzRhFgA_CkWzj8z09ef59uKDlGTgeZ9gF-_ZUpdx_TZiKXd9dLyVd3jK4-LuTn7A9xG7Uy</recordid><startdate>200412</startdate><enddate>200412</enddate><creator>ALEXIA, CATHERINE</creator><creator>LASFER, MALIKA</creator><creator>GROYER, ANDRÉ</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200412</creationdate><title>Role of Constitutively Activated and Insulin-Like Growth Factor-Stimulated ERK1/2 Signaling in Human Hepatoma Cell Proliferation and Apoptosis: Evidence for Heterogeneity of Tumor Cell Lines</title><author>ALEXIA, CATHERINE ; LASFER, MALIKA ; GROYER, ANDRÉ</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4199-64076a63445284d65d902fa2d3aa15620d87cb40f26d07b5cedb4e47111c09693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Carcinoma, Hepatocellular - enzymology</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Cell Division</topic><topic>Cell Line, Tumor</topic><topic>DNA Replication - drug effects</topic><topic>human hepatoma cell lines</topic><topic>Humans</topic><topic>Insulin-Like Growth Factor I - pharmacology</topic><topic>Insulin-Like Growth Factor II - pharmacology</topic><topic>insulin-like growth factors</topic><topic>Liver Neoplasms - enzymology</topic><topic>Liver Neoplasms - pathology</topic><topic>MAP kinase (ERK) signaling</topic><topic>Mitogen-Activated Protein Kinases - metabolism</topic><topic>proliferation</topic><topic>Signal Transduction - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ALEXIA, CATHERINE</creatorcontrib><creatorcontrib>LASFER, MALIKA</creatorcontrib><creatorcontrib>GROYER, ANDRÉ</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of the New York Academy of Sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ALEXIA, CATHERINE</au><au>LASFER, MALIKA</au><au>GROYER, ANDRÉ</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of Constitutively Activated and Insulin-Like Growth Factor-Stimulated ERK1/2 Signaling in Human Hepatoma Cell Proliferation and Apoptosis: Evidence for Heterogeneity of Tumor Cell Lines</atitle><jtitle>Annals of the New York Academy of Sciences</jtitle><addtitle>Ann N Y Acad Sci</addtitle><date>2004-12</date><risdate>2004</risdate><volume>1030</volume><issue>1</issue><spage>219</spage><epage>229</epage><pages>219-229</pages><issn>0077-8923</issn><eissn>1749-6632</eissn><abstract>: Enhanced insulin‐like growth factor II (IGF‐II) and type I IGF receptor (IGF‐IR) gene expression in liver tumors and the development of liver tumors in transgenic mice overexpressing IGF‐II in the liver suggest that the IGFs and underlying signaling cascades may play auto/paracrine roles in the control of hepatocarcinoma (HCC) cell proliferation and in their protection against apoptosis. We have focused on the role of mitogen‐activated protein kinase (ERK1/2) signaling on human HepG2 and Huh‐7 hepatoma cell proliferation and on the protection of these cells against drug‐induced apoptosis. Physiological concentrations of IGF‐I stimulated DNA replication in HepG2 cells (1.5‐fold) but not in Huh‐7 cells, and this effect was abolished by PD98059 (MEK‐1 inhibitor). Doxorubicin or cisplatin treatment induced apoptosis (caspase‐dependent poly[ADP‐ribose]polymerase cleavage) in both cell lines, but dose‐dependent reversion of drug‐induced apoptosis (57–84%) by IGF‐I was only observed in HepG2 cells. The very low level of IGF‐IR at the plasma membrane of Huh‐7 cells may account for their unresponsiveness to IGF‐I. We have shown that drug treatment enhanced (17‐fold) or did not modify constitutive ERK1/2 activity in cultured HepG2 or Huh‐7 cells, respectively. In both cell lines, inhibition of constitutive and drug‐induced ERK1/2 activity by PD98059 yielded a complete inhibition of drug‐induced apoptosis. Altogether, our data demonstrate the heterogeneous response of human hepatoma cells to an IGF stimulus and suggest (1) that auto/paracrine effects of IGF‐I/‐II might contribute to the proliferation of HCC cells and to their protection against apoptosis in vivo and (2) that drug‐induced activation of ERK1/2 plays a role in drug‐induced apoptosis in human hepatoma cells.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>15659801</pmid><doi>10.1196/annals.1329.028</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0077-8923
ispartof Annals of the New York Academy of Sciences, 2004-12, Vol.1030 (1), p.219-229
issn 0077-8923
1749-6632
language eng
recordid cdi_proquest_miscellaneous_67218223
source Wiley-Blackwell Read & Publish Collection
subjects apoptosis
Apoptosis - drug effects
Carcinoma, Hepatocellular - enzymology
Carcinoma, Hepatocellular - pathology
Cell Division
Cell Line, Tumor
DNA Replication - drug effects
human hepatoma cell lines
Humans
Insulin-Like Growth Factor I - pharmacology
Insulin-Like Growth Factor II - pharmacology
insulin-like growth factors
Liver Neoplasms - enzymology
Liver Neoplasms - pathology
MAP kinase (ERK) signaling
Mitogen-Activated Protein Kinases - metabolism
proliferation
Signal Transduction - drug effects
title Role of Constitutively Activated and Insulin-Like Growth Factor-Stimulated ERK1/2 Signaling in Human Hepatoma Cell Proliferation and Apoptosis: Evidence for Heterogeneity of Tumor Cell Lines
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A06%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20Constitutively%20Activated%20and%20Insulin-Like%20Growth%20Factor-Stimulated%20ERK1/2%20Signaling%20in%20Human%20Hepatoma%20Cell%20Proliferation%20and%20Apoptosis:%20Evidence%20for%20Heterogeneity%20of%20Tumor%20Cell%20Lines&rft.jtitle=Annals%20of%20the%20New%20York%20Academy%20of%20Sciences&rft.au=ALEXIA,%20CATHERINE&rft.date=2004-12&rft.volume=1030&rft.issue=1&rft.spage=219&rft.epage=229&rft.pages=219-229&rft.issn=0077-8923&rft.eissn=1749-6632&rft_id=info:doi/10.1196/annals.1329.028&rft_dat=%3Cproquest_cross%3E67218223%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4199-64076a63445284d65d902fa2d3aa15620d87cb40f26d07b5cedb4e47111c09693%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67218223&rft_id=info:pmid/15659801&rfr_iscdi=true